$28.95
1.475.35%
Last update: Oct 12, 7:40 PM
$29.58
2.107.64%
Parabilis Medicines Inc
PBLSNASDAQ
Parabilis Medicines (PBLS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-2.32 | $-0.23 | -908.7 % |
Quarterly Revenue (Billions)
| Metric | Q2 '26 |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Estimate | $-0.23 |
| Actual | $-2.32 |
| Surprise | -908.7% |
| Revenue | |
| Estimate | $16.7M |
| Actual | $148000 |
| Surprise | -99.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.39 | $-0.37 | $-0.29 | $-0.30 |
| Revenue | ||||
| Consensus | $500000 | $1.0M | — | — |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $148.00K | $16.67M | -99.1 % |
